\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\ approximately\\ 100\\ soft\\,\\ skin\\ colored\\-to\\-pink\\,\\ 2\\-20\\ mm\\ well\\ circumscribed\\ papules\\ and\\ plaques\\ were\\ present\\ over\\ the\\ face\\,\\ neck\\ upper\\ trunk\\,\\ and\\ arms\\.\\ the\\ overlying\\ skin\\ was\\ wrinkled\\ and\\ atrophic\\,\\ demonstrating\\ herniation\\ upon\\ palpation\\.\\ the\\ lesions\\ were\\ clinically\\ non\\-inflammatory\\.\\ the\\ remainder\\ of\\ his\\ physical\\ exam\\ revealed\\ no\\ bony\\,\\ ocular\\ or\\ cardiac\\ abnormalities\\.\ \(0\)\
\-\ laboratory\\:\\ laboratory\\ evaluation\\ showed\\ a\\ positive\\ anti\\-dna\\ antibody\\ titer\\ at\\ 149\\ \\(\\>100\\ positive\\)\\ and\\ elevated\\ anticardiolipin\\ igg\\ at\\ 47\\ \\(nl\\ 0\\-22\\)\\.\\ cbc\\,\\ ua\\,\\ thyroid\\ function\\ tests\\,\\ serum\\ protein\\ electrophoresis\\,\\ lyme\\ titer\\,\\ rpr\\,\\ hiv\\,\\ and\\ anticardiolipin\\ iga\\ and\\ igm\\ were\\ unremarkable\\.\ \(0\)\
\-\ histopathology\\:\\ hematoxylin\\ and\\ eosin\\ staining\\ of\\ an\\ excisional\\ biopsy\\ revealed\\ a\\ superficial\\ and\\ deep\\ perivascular\\ lymphohistiocytic\\ dermatitis\\ with\\ scattered\\ eosinophils\\ and\\ focal\\ vacuolar\\ change\\.\\ a\\ verhoff\\-von\\ giesen\\ elastic\\ tissue\\ stain\\ demonstrated\\ the\\ classic\\ histological\\ finding\\ of\\ anetoderma\\-\\-focal\\ loss\\ of\\ elastic\\ tissue\\ in\\ the\\ reticular\\ dermis\\.\\ direct\\ immunofluorescence\\ was\\ negative\\ for\\ immunoglobulins\\,\\ c3\\,\\ and\\ fibinogen\\.\ \(0\)\
\-\ the\\ patient\\ continues\\ to\\ form\\ new\\ lesions\\.\ \(0\)\
\-\ primary\\ anetoderma\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#3\\)rita\\ m\\.\\ ricci\\,\\ maj\\,\\ usaf\\,\\ mc\\,\\ fs\\;\\ jeffrey\\ j\\.\\ meffert\\,\\ ltc\\,\\ usaf\\,\\ mc\\,\\ fs\\;\\ martha\\ l\\.\\ mccollough\\,\\ col\\,\\ mc\\,\\ usa\ \(0\)\
\-\ patient\\ presented\\ with\\ a\\ 6\\ year\\ history\\ of\\ progressive\\ crops\\ of\\ asymptomatic\\ lesions\\ on\\ his\\ face\\,\\ neck\\,\\ upper\\ trunk\\,\\ and\\ arms\\.\\ the\\ patient\\ was\\ otherwise\\ in\\ good\\ health\\ and\\ took\\ no\\ medications\\.\\ he\\ has\\ no\\ family\\ history\\ of\\ skin\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ anetoderma\\:\\ 0\\.06274390337342703\ \(0\)\
\-\ anticardiolipin\\:\\ 0\\.057810471483320656\ \(0\)\
\-\ mc\\:\\ 0\\.05347533025832219\ \(0\)\
\-\ titer\\:\\ 0\\.047105294282066036\ \(0\)\
\-\ elastic\\:\\ 0\\.047105294282066036\ \(0\)\
\-\ usaf\\:\\ 0\\.04635539737346941\ \(0\)\
\-\ fs\\:\\ 0\\.04346952471789529\ \(0\)\
\-\ trunk\\:\\ 0\\.03830271330591709\ \(0\)\
\-\ skin\\:\\ 0\\.03504052244027379\ \(0\)\
\-\ arms\\:\\ 0\\.03396773776606368\ \(0\)\
\-\ colored\\-to\\-pink\\:\\ 0\\.031371951686713515\ \(0\)\
\-\ 2\\-20\\:\\ 0\\.031371951686713515\ \(0\)\
\-\ 0\\-22\\:\\ 0\\.031371951686713515\ \(0\)\
\-\ hematoxylin\\:\\ 0\\.031371951686713515\ \(0\)\
\-\ eosin\\:\\ 0\\.031371951686713515\ \(0\)\
\-\ verhoff\\-von\\:\\ 0\\.031371951686713515\ \(0\)\
\-\ giesen\\:\\ 0\\.031371951686713515\ \(0\)\
\-\ fibinogen\\:\\ 0\\.031371951686713515\ \(0\)\
\-\ ricci\\:\\ 0\\.031371951686713515\ \(0\)\
\-\ ltc\\:\\ 0\\.031371951686713515\ \(0\)\
\-\ 100\\:\\ 0\\.030716788282108422\ \(0\)\
\-\ face\\:\\ 0\\.029825947406990936\ \(0\)\
\-\ wrinkled\\:\\ 0\\.028905235741660328\ \(0\)\
\-\ non\\-inflammatory\\:\\ 0\\.028905235741660328\ \(0\)\
\-\ anti\\-dna\\:\\ 0\\.028905235741660328\ \(0\)\
\-\ 149\\:\\ 0\\.028905235741660328\ \(0\)\
\-\ rita\\:\\ 0\\.028905235741660328\ \(0\)\
\-\ meffert\\:\\ 0\\.028905235741660328\ \(0\)\
\-\ \\,\\:\\ 0\\.028901430482272675\ \(0\)\
\-\ immunofluorescence\\:\\ 0\\.027462299413873268\ \(0\)\
\-\ martha\\:\\ 0\\.027462299413873268\ \(0\)\
\-\ mccollough\\:\\ 0\\.027462299413873268\ \(0\)\
\-\ col\\:\\ 0\\.027462299413873268\ \(0\)\
\-\ lymphohistiocytic\\:\\ 0\\.026438519796607142\ \(0\)\
\-\ vacuolar\\:\\ 0\\.026438519796607142\ \(0\)\
\-\ crops\\:\\ 0\\.026438519796607142\ \(0\)\
\-\ electrophoresis\\:\\ 0\\.024995583468820082\ \(0\)\
\-\ immunoglobulins\\:\\ 0\\.02444700453705048\ \(0\)\
\-\ lesions\\:\\ 0\\.02442235416025567\ \(0\)\
\-\ iga\\:\\ 0\\.023552647141033018\ \(0\)\
\-\ rpr\\:\\ 0\\.022528867523766895\ \(0\)\
\-\ laboratory\\:\\ 0\\.02241346431212858\ \(0\)\
\-\ igm\\:\\ 0\\.022244018030266766\ \(0\)\
\-\ eosinophils\\:\\ 0\\.021734762358947644\ \(0\)\
\-\ maj\\:\\ 0\\.02150508790650077\ \(0\)\
\-\ dermatitis\\:\\ 0\\.021085931195979835\ \(0\)\
\-\ usa\\:\\ 0\\.021085931195979835\ \(0\)\
\-\ igg\\:\\ 0\\.02089352115587209\ \(0\)\
\-\ were\\:\\ 0\\.02071480074757923\ \(0\)\
\-\ excisional\\:\\ 0\\.020710982741681518\ \(0\)\
\-\ perivascular\\:\\ 0\\.020710982741681518\ \(0\)\
\-\ atrophic\\:\\ 0\\.02053735226421023\ \(0\)\
\-\ antibody\\:\\ 0\\.0202136092812717\ \(0\)\
\-\ staining\\:\\ 0\\.0202136092812717\ \(0\)\
\-\ took\\:\\ 0\\.019916877576862266\ \(0\)\
\-\ papules\\:\\ 0\\.01977730208521358\ \(0\)\
\-\ reticular\\:\\ 0\\.01977730208521358\ \(0\)\
\-\ positive\\:\\ 0\\.019735840500242824\ \(0\)\
\-\ revealed\\:\\ 0\\.019519387116484647\ \(0\)\
\-\ dermis\\:\\ 0\\.019513572646944106\ \(0\)\
\-\ c3\\:\\ 0\\.019268046413894457\ \(0\)\
\-\ l\\.\\:\\ 0\\.019268046413894457\ \(0\)\
\-\ nl\\:\\ 0\\.019038371961447583\ \(0\)\
\-\ histological\\:\\ 0\\.018928864279359494\ \(0\)\
\-\ lyme\\:\\ 0\\.018822625976335716\ \(0\)\
\-\ stain\\:\\ 0\\.018719467482124854\ \(0\)\
\-\ jeffrey\\:\\ 0\\.018719467482124854\ \(0\)\
\-\ ocular\\:\\ 0\\.018426805210818905\ \(0\)\
\-\ j\\.\\:\\ 0\\.017905084662093368\ \(0\)\
\-\ neck\\:\\ 0\\.017859381758138664\ \(0\)\
\-\ m\\.\\:\\ 0\\.017825110086107397\ \(0\)\
\-\ his\\:\\ 0\\.01752945927150841\ \(0\)\
\-\ focal\\:\\ 0\\.01737006123941923\ \(0\)\
\-\ 1997\\:\\ 0\\.01704685670189092\ \(0\)\
\-\ plaques\\:\\ 0\\.01698386888303184\ \(0\)\
\-\ histopathology\\:\\ 0\\.01698386888303184\ \(0\)\
\-\ seminar\\:\\ 0\\.016921976560213804\ \(0\)\
\-\ hiv\\:\\ 0\\.016861142277796365\ \(0\)\
\-\ health\\:\\ 0\\.016861142277796365\ \(0\)\
\-\ uniformed\\:\\ 0\\.016742507330224865\ \(0\)\
\-\ services\\:\\ 0\\.016408632756496556\ \(0\)\
\-\ dermatology\\:\\ 0\\.016408632756496556\ \(0\)\
\-\ superficial\\:\\ 0\\.016252751537071668\ \(0\)\
\-\ ua\\:\\ 0\\.016152499305873463\ \(0\)\
\-\ 47\\:\\ 0\\.01596008926576572\ \(0\)\
\-\ tests\\:\\ 0\\.015913569402536704\ \(0\)\
\-\ continues\\:\\ 0\\.015867649812373333\ \(0\)\
\-\ protein\\:\\ 0\\.015603920374103858\ \(0\)\
\-\ physical\\:\\ 0\\.014921745690969667\ \(0\)\
\-\ serum\\:\\ 0\\.01467676349372724\ \(0\)\
\-\ upper\\:\\ 0\\.014676729575578066\ \(0\)\
\-\ tissue\\:\\ 0\\.014415809170481093\ \(0\)\
\-\ \\;\\:\\ 0\\.014415809170481093\ \(0\)\
\-\ direct\\:\\ 0\\.014364394771725866\ \(0\)\
\-\ remainder\\:\\ 0\\.014334614523788087\ \(0\)\
\-\ form\\:\\ 0\\.014217924762852175\ \(0\)\
\-\ scattered\\:\\ 0\\.014160984046316797\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.013968574006209055\ \(0\)\
\-\ overlying\\:\\ 0\\.013760706525225373\ \(0\)\
\-\ cbc\\:\\ 0\\.013588278114599228\ \(0\)\
\-\ medications\\:\\ 0\\.013564313587263484\ \(0\)\
\-\ herniation\\:\\ 0\\.013540509358968833\ \(0\)\
\-\ circumscribed\\:\\ 0\\.013516863299471792\ \(0\)\
\-\ exam\\:\\ 0\\.01336109565800383\ \(0\)\
\-\ clinically\\:\\ 0\\.013333146696605932\ \(0\)\
\-\ demonstrating\\:\\ 0\\.01320132722443387\ \(0\)\
\-\ good\\:\\ 0\\.013012324287373556\ \(0\)\
\-\ function\\:\\ 0\\.012891678196001025\ \(0\)\
\-\ thyroid\\:\\ 0\\.012463745355603953\ \(0\)\
\-\ family\\:\\ 0\\.012463745355603953\ \(0\)\
\-\ upon\\:\\ 0\\.012428855675544803\ \(0\)\
\-\ deep\\:\\ 0\\.012309367079339805\ \(0\)\
\-\ bony\\:\\ 0\\.012161408264942154\ \(0\)\
\-\ \\:\\:\\ 0\\.012066990918049804\ \(0\)\
\-\ progressive\\:\\ 0\\.012019356281292892\ \(0\)\
\-\ \\#\\:\\ 0\\.011927710387689994\ \(0\)\
\-\ change\\:\\ 0\\.011853101389593747\ \(0\)\
\-\ classic\\:\\ 0\\.011652152593623032\ \(0\)\
\-\ cardiac\\:\\ 0\\.011583049085234769\ \(0\)\
\-\ mm\\:\\ 0\\.011182189170088987\ \(0\)\
\-\ abnormalities\\:\\ 0\\.011169980860136002\ \(0\)\
\-\ otherwise\\:\\ 0\\.010922830012193397\ \(0\)\
\-\ biopsy\\:\\ 0\\.010788943920415517\ \(0\)\
\-\ new\\:\\ 0\\.010597110237724406\ \(0\)\
\-\ was\\:\\ 0\\.010551005575235091\ \(0\)\
\-\ elevated\\:\\ 0\\.010317851819783142\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.010279688249096395\ \(0\)\
\-\ palpation\\:\\ 0\\.010149249396256412\ \(0\)\
\-\ \\>\\:\\ 0\\.010103798984585638\ \(0\)\
\-\ unremarkable\\:\\ 0\\.010067852023779574\ \(0\)\
\-\ showed\\:\\ 0\\.009970830134959774\ \(0\)\
\-\ finding\\:\\ 0\\.009800930622912745\ \(0\)\
\-\ approximately\\:\\ 0\\.009408604364966487\ \(0\)\
\-\ no\\:\\ 0\\.009186236484382227\ \(0\)\
\-\ patient\\:\\ 0\\.009145109582737239\ \(0\)\
\-\ negative\\:\\ 0\\.009082278154358983\ \(0\)\
\-\ 6\\:\\ 0\\.009082278154358983\ \(0\)\
\-\ primary\\:\\ 0\\.009008484921336997\ \(0\)\
\-\ demonstrated\\:\\ 0\\.008923202784544367\ \(0\)\
\-\ evaluation\\:\\ 0\\.00883359002073597\ \(0\)\
\-\ loss\\:\\ 0\\.008827274635119002\ \(0\)\
\-\ he\\:\\ 0\\.008484652462750958\ \(0\)\
\-\ history\\:\\ 0\\.008400103471224793\ \(0\)\
\-\ presented\\:\\ 0\\.008289528950257684\ \(0\)\
\-\ at\\:\\ 0\\.008240307137591694\ \(0\)\
\-\ over\\:\\ 0\\.007742500320782784\ \(0\)\
\-\ \\(\\:\\ 0\\.007712046899400646\ \(0\)\
\-\ and\\:\\ 0\\.007687217326642781\ \(0\)\
\-\ \\)\\:\\ 0\\.007617840129323542\ \(0\)\
\-\ soft\\:\\ 0\\.007405433323820462\ \(0\)\
\-\ 3\\:\\ 0\\.007120909347710105\ \(0\)\
\-\ well\\:\\ 0\\.00687929164757527\ \(0\)\
\-\ present\\:\\ 0\\.006868358554917013\ \(0\)\
\-\ case\\:\\ 0\\.006653040686360394\ \(0\)\
\-\ has\\:\\ 0\\.00571067605158106\ \(0\)\
\-\ a\\:\\ 0\\.005645548780335961\ \(0\)\
\-\ disease\\:\\ 0\\.004970596232084356\ \(0\)\
\-\ an\\:\\ 0\\.004205213040159181\ \(0\)\
\-\ the\\:\\ 0\\.003935922696188634\ \(0\)\
\-\ or\\:\\ 0\\.0035641378966679983\ \(0\)\
\-\ year\\:\\ 0\\.0034025098550637535\ \(0\)\
\-\ in\\:\\ 0\\.0029992685419235224\ \(0\)\
\-\ of\\:\\ 0\\.0029022299131171493\ \(0\)\
\-\ for\\:\\ 0\\.0025946909204367084\ \(0\)\
\-\ on\\:\\ 0\\.0025761245991652243\ \(0\)\
\-\ \\.\\:\\ 0\\.001642327292759792\ \(0\)\
\-\ to\\:\\ 0\\.0015198153325373177\ \(0\)\
\-\ with\\:\\ 0\\.000832769936582845\ \(0\)\
